Medtronic PLC
USUSDMedtronic PLC (XETRA:2M6) — Medical Devices. Biržu skaits, kurās tiek tirgotas uzņēmuma akcijas: 5. Šajā lapā — cena un grafiks, dividendes, lielākie akcionāri un akciju skaita vēsture.
Par Uzņēmumu
- Tīmekļvietne
- medtronic.com
- Nozare
- Healthcare · Medical Devices
- Galvenā Mītne
- GALWAY, Ireland
- Izpilddirektors
- Geoffrey Straub Martha
- Darbinieki
- 95 000
- Dibināts
- 1949
- Apgrozībā Esošās Akcijas
- Brīvā Apgrozība
- 1.28 mljrd.
- Tirgus Kapitalizācija
- 113.38 mljrd. USD
- Iekšējās Personas
- 0.39%
- Institucionālie Investori
- 88.68%
- Nozare (SIC)
- Electromedical & Electrotherapeutic Apparatus
- ISIN
- IE00BTN1Y115
- Izmaksas Koeficients
- 69.8%
- FCF
- 6.13 mljrd. USD60%
- Parāds
- 25.6 mljrd. USD3.9 g. FCF
- Dividenžu Stāžs
- 44 g.
- Peļņa, FCF un izmaksātās dividendes — par 12 mēnešiem līdz 31.07.2026 (uzņēmuma jaunākais ziņojums).
Apraksts
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Biržas un Tikeri
| Birža | Tikeris | Valūta | Cena | Veids |
|---|---|---|---|---|
| US USA Stocks | MDT galvenā | USD | 92 +3.98% | parastās akcijas |
| LSE London Stock Exchange | 0Y6X IOB | USD | 87.27 +0.00% | parastās akcijas |
| MI Borsa Italiana (Milan) | 1MDT papildu | EUR | 81.86 +4.23% | parastās akcijas |
| VI Vienna Stock Exchange | MDT papildu | EUR | 77.34 -0.74% | parastās akcijas |
| XETRA Xetra | 2M6 papildu | EUR | 77.72 +0.73% | parastās akcijas |
Dividendes
Medtronic PLC (2M6) izmaksā dividendes reizi ceturksnī. Gadā (12 mēneši līdz jaunākajam paziņotajam maksājumam): 2.5242 EUR par akciju (maksājumi: 4). Tas ir aptuveni 3.25% no pašreizējās akciju cenas. Pamatojoties uz maksājumu vēsturi, nākamais ex-dividendes datums tiek gaidīts ap 25.12.2026. Nepārtrauktu dividenžu gadi: 44.
| Ex-Datums | Izmaksa | Summa | % | Veids | Tikeris |
|---|---|---|---|---|---|
| 2026-09-25 | — | 0.6355 EUR | 0.8/3.2 % | ceturkšņa | XETRA:2M6 |
| 2026-06-26 | — | 0.6355 EUR | 0.8/3.2 % | ceturkšņa | XETRA:2M6 |
| 2026-03-27 | — | 0.6266 EUR | 0.8/3.2 % | ceturkšņa | XETRA:2M6 |
| 2025-12-29 | — | 0.6266 EUR | 0.8/3.2 % | ceturkšņa | XETRA:2M6 |
| 2025-09-26 | — | 0.6266 EUR | 0.8/3.2 % | ceturkšņa | XETRA:2M6 |
| 2025-06-27 | — | 0.6266 EUR | 0.8/3.2 % | ceturkšņa | XETRA:2M6 |
| 2025-03-28 | — | 0.6178 EUR | 0.8/3.2 % | ceturkšņa | XETRA:2M6 |
| 2024-12-27 | — | 0.6178 EUR | 0.8/3.2 % | ceturkšņa | XETRA:2M6 |
| 2024-09-27 | — | 0.6178 EUR | 0.8/3.2 % | ceturkšņa | XETRA:2M6 |
| 2024-06-28 | — | 0.6178 EUR | 0.8/3.1 % | ceturkšņa | XETRA:2M6 |
| 2024-03-21 | — | 0.6090 EUR | 0.8/3.1 % | ceturkšņa | XETRA:2M6 |
| 2023-12-19 | — | 0.6090 EUR | 0.8/3.1 % | ceturkšņa | XETRA:2M6 |
| 2023-09-21 | — | 0.6090 EUR | 0.8/3.1 % | ceturkšņa | XETRA:2M6 |
| 2023-06-22 | — | 0.6090 EUR | 0.8/3.1 % | ceturkšņa | XETRA:2M6 |
| 2023-03-23 | — | 0.6002 EUR | 0.8/3.1 % | ceturkšņa | XETRA:2M6 |
| 2022-12-20 | — | 0.6002 EUR | 0.8/3.0 % | ceturkšņa | XETRA:2M6 |
| 2022-09-22 | — | 0.6002 EUR | 0.8/3.0 % | ceturkšņa | XETRA:2M6 |
| 2022-06-23 | — | 0.6002 EUR | 0.8/2.2 % | ceturkšņa | XETRA:2M6 |
| 2022-03-24 | — | 0.5560 EUR | 0.7/1.4 % | ceturkšņa | XETRA:2M6 |
| 2021-12-21 | — | 0.5560 EUR | 0.7/0.7 % | ceturkšņa | XETRA:2M6 |
Lielākie Akcionāri
| Turētājs | Daļa | Akcijas | Pārskata Datums |
|---|---|---|---|
| Blackrock Inc. | 8.91% | 114.02 milj. | 2026-06-30 |
| Vanguard Capital Managem… | 6.55% | 83.82 milj. | 2026-06-30 |
| State Street Corporation | 4.96% | 63.4 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.19% | 40.76 milj. | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.66% | 34.06 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.6% | 33.27 milj. | 2026-06-30 |
| Geode Capital Management… | 2.36% | 30.19 milj. | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.17% | 27.78 milj. | 2026-06-30 |
| Bank of America Corporat… | 1.67% | 21.32 milj. | 2026-06-30 |
| Massachusetts Financial… | 1.55% | 19.87 milj. | 2026-06-30 |
| Morgan Stanley | 1.52% | 19.44 milj. | 2026-06-30 |
| Deutsche Bank AG | 1.44% | 18.45 milj. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.35% | 17.32 milj. | 2026-07-31 |
| Fidelity Concord Street… | 1.3% | 16.6 milj. | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 15.69 milj. | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 0.96% | 12.22 milj. | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 9.23 milj. | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 0.56% | 7.2 milj. | 2026-04-30 |
| VANGUARD INSTITUTIONAL I… | 0.54% | 6.97 milj. | 2026-06-30 |
| First Eagle Funds-First… | 0.52% | 6.66 milj. | 2026-04-30 |
| MARTHA GEOFFREY S (Chief… | ≈0.03% | 327 866 | 2026-08-03 |
| MARINARO MICHAEL (Office… | ≈0.01% | 117 420 | 2026-08-03 |
| WALL BRETT A (Officer) | ≈0.01% | 82 183 | 2026-05-26 |
| POWELL KENDALL J (Direct… | ≈0% | 51 380 | 2026-04-27 |
| PIETON THIERRY JEAN LOUI… | ≈0% | 49 645 | 2026-08-03 |
| HOGAN RANDALL J III (Dir… | ≈0% | 48 998 | 2026-04-27 |
| SMITH GREGORY L (Officer… | ≈0% | 46 016 | 2025-11-19 |
| CORONA GARY LOUIS (Chief… | ≈0% | 44 255 | 2025-01-21 |
| KIIL HARRY SKIP (Officer… | ≈0% | 42 186 | 2026-09-16 |
| ARNOLD CRAIG (Director) | ≈0% | 42 185 | 2026-04-27 |
Pieslēdzies ar Google